Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.030
+0.030 (1.50%)
At close: May 20, 2025, 4:00 PM
2.080
+0.050 (2.46%)
After-hours: May 20, 2025, 7:56 PM EDT
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $12.52 million as of May 20, 2025. Its market cap has decreased by -25.45% in one year.
Market Cap
12.52M
Enterprise Value
15.96M
1-Year Change
-25.45%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $12.52M, an increase of 6,162.40%. That is a compound annual growth rate of 50.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 12.50M | 19.05% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.62B |
| Johnson & Johnson | 369.72B |
| AbbVie | 326.52B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 291.72B |
| Abbott Laboratories | 235.23B |
| Novartis AG | 219.90B |
| AstraZeneca | 215.95B |